Polycyclic aromatic hydrocarbon-DNA adducts in humans: relevance as biomarkers for exposure and cancer risk.
暂无分享,去创建一个
H. Bartsch | H Bartsch | E Kriek | M Rojas | K Alexandrov | M. Rojas | K. Alexandrov | E. Kriek | Helmut Bartsch | K. Alexandrov | E. Kriek
[1] D. Phillips,et al. Smoking-associated bulky DNA adducts in bronchial tissue related to CYP1A1 MspI and GSTM1 genotypes in lung patients. , 1998, Carcinogenesis.
[2] H. Bartsch,et al. High benzo[a]pyrene diol-epoxide DNA adduct levels in lung and blood cells from individuals with combined CYP1A1 MspI/Msp-GSTM1*0/*0 genotypes. , 1998, Pharmacogenetics.
[3] R. Baan,et al. The use of benzo[a]pyrene diolepoxide-modified DNA standards for adduct quantification in 32P-postlabelling to assess exposure to polycyclic aromatic hydrocarbons: application in a biomonitoring study. , 1997, Mutation research.
[4] L. V. van't Veer,et al. 32P-postlabelling of aromatic DNA adducts in white blood cells and alveolar macrophages of smokers: saturation at high exposures. , 1997, Mutation research.
[5] D. Phillips. Detection of DNA modifications by the 32P-postlabelling assay. , 1997, Mutation research.
[6] J. Lewtas,et al. Air pollution exposure-DNA adduct dosimetry in humans and rodents: evidence for non-linearity at high doses. , 1997, Mutation research.
[7] F P Perera,et al. Contribution of genetic and nutritional factors to DNA damage in heavy smokers. , 1997, Carcinogenesis.
[8] Yu-jing Zhang,et al. Immunoperoxidase quantitation of 4-aminobiphenyl- and polycyclic aromatic hydrocarbon-DNA adducts in exfoliated oral and urothelial cells of smokers and nonsmokers. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[9] F. Perera,et al. Aromatic DNA adducts in foundry workers in relation to exposure, life style and CYP1A1 and glutathione transferase M1 genotype. , 1997, Carcinogenesis.
[10] S. Parodi,et al. Detection of DNA adducts in human nasal mucosa tissue by 32P-postlabeling analysis. , 1997, Carcinogenesis.
[11] M. Tang,et al. Preferential Formation of Benzo[a]pyrene Adducts at Lung Cancer Mutational Hotspots in P53 , 1996, Science.
[12] D. Phillips,et al. p53 mutations in lung tumours: relationship to gender and lung DNA adduct levels. , 1996, Carcinogenesis.
[13] H. Bartsch,et al. Evidence of anti-benzo[a]pyrene diolepoxide-DNA adduct formation in human colon mucosa. , 1996, Carcinogenesis.
[14] J. Kleinjans,et al. Enhanced DNA damage in heart tissue of cigarette smokers , 1996 .
[15] P. S. Nielsen,et al. Comparative synchronous fluorescence spectrophotometry and 32P-postlabeling analysis of PAH-DNA adducts in human lung and the relationship to TP53 mutations. , 1996, Mutation research.
[16] P. S. Nielsen,et al. Biomonitoring of diesel exhaust-exposed workers. DNA and hemoglobin adducts and urinary 1-hydroxypyrene as markers of exposure. , 1996, Toxicology letters.
[17] H. Bartsch. DNA adducts in human carcinogenesis: etiological relevance and structure-activity relationship. , 1996, Mutation research.
[18] P. S. Nielsen,et al. Environmental air pollution and DNA adducts in Copenhagen bus drivers--effect of GSTM1 and NAT2 genotypes on adduct levels. , 1996, Carcinogenesis.
[19] H. Bartsch,et al. The role of individual susceptibility in cancer burden related to environmental exposure. , 1996, Environmental health perspectives.
[20] J. Lewtas,et al. Biomarker studies in northern Bohemia. , 1996, Environmental health perspectives.
[21] R. Santella,et al. A sensitive color ELISA for detecting polycyclic aromatic hydrocarbon-DNA adducts in human tissues. , 1996, Mutation research.
[22] Donghui Li,et al. Aromatic DNA adducts in adjacent tissues of breast cancer patients: clues to breast cancer etiology. , 1996, Cancer research.
[23] K. Hemminki,et al. Seasonal variation of DNA adduct pattern in human lymphocytes analyzed by 32P-HPLC. , 1996, Carcinogenesis.
[24] E. Mark,et al. Correlation of DNA adducts in blood mononuclear cells with tobacco carcinogen-induced damage in human lung. , 1995, Cancer research.
[25] N. Rothman,et al. The impact of glutathione s‐transferase M1 and cytochrome P450 1A1 genotypes on white‐blood‐cell polycyclic aromatic hydrocarbon‐dna adduct levels in humans , 1995, Molecular carcinogenesis.
[26] T B Cooper,et al. Decline of DNA damage and other biomarkers in peripheral blood following smoking cessation. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[27] E. Bowman,et al. Human Lung Carcinogen—DNA Adduct Levels Mediated by Genetic Polymorphisms In Vivo , 1995 .
[28] F P Perera,et al. A molecular epidemiological case-control study of lung cancer. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[29] H. Bartsch,et al. Anti-benzo[a]pyrene diolepoxide--DNA adduct levels in peripheral mononuclear cells from coke oven workers and the enhancing effect of smoking. , 1995, Carcinogenesis.
[30] B S Schwartz,et al. Interindividual differences in the concentration of 1-hydroxypyrene-glucuronide in urine and polycyclic aromatic hydrocarbon-DNA adducts in peripheral white blood cells after charbroiled beef consumption. , 1995, Carcinogenesis.
[31] J. Lewtas,et al. DNA adducts and personal air monitoring of carcinogenic polycyclic aromatic hydrocarbons in an environmentally exposed population. , 1995, Carcinogenesis.
[32] F. Perera,et al. Polycyclic aromatic hydrocarbon-DNA and protein adducts in coal tar treated patients and controls and their relationship to glutathione S-transferase genotype. , 1995, Mutation research.
[33] F. Perera,et al. Immunohistochemical quantitation of polycyclic aromatic hydrocarbon-DNA adducts in human lymphocytes. , 1995, Cancer research.
[34] N. J. Jones,et al. Development of a human biomonitoring assay using buccal mucosa: comparison of smoking-related DNA adducts in mucosa versus biopsies. , 1995, Cancer research.
[35] J. Lewtas,et al. Cancer biomarkers in human atherosclerotic lesions: detection of DNA adducts. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[36] F J van Schooten,et al. Polycyclic aromatic hydrocarbon-DNA adducts in white blood cell DNA and 1-hydroxypyrene in the urine from aluminum workers: relation with job category and synergistic effect of smoking. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[37] C. Vahrenholz,et al. Risk estimation in coke-oven workers by determining some biomarkers of carcinogen exposure. , 1995, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.
[38] H. Bartsch,et al. Metabolic polymorphism affecting DNA binding and excretion of carcinogens in humans. , 1995, Pharmacogenetics.
[39] F. Perera,et al. Carcinogen-DNA adducts and gene mutation in foundry workers with low-level exposure to polycyclic aromatic hydrocarbons. , 1994, Carcinogenesis.
[40] D. Phillips,et al. Different susceptibility to smoking-induced DNA damage among male and female lung cancer patients. , 1994, Cancer research.
[41] F. Perera,et al. Polycyclic aromatic hydrocarbon-DNA adducts in smokers and their relationship to micronutrient levels and the glutathione-S-transferase M1 genotype. , 1994, Carcinogenesis.
[42] K. Hemminki,et al. Aromatic DNA adducts in larynx biopsies and leukocytes. , 1994, Carcinogenesis.
[43] F. Guengerich,et al. Metabolic activation and carcinogen-DNA adduct detection in human larynx. , 1994, Cancer research.
[44] K. Hemminki,et al. Aromatic DNA adducts, micronuclei and genetic polymorphism for CYP1A1 and GST1 in chimney sweeps. , 1994, Carcinogenesis.
[45] D. Ryberg,et al. p53 mutations in lung tumors: relationship to putative susceptibility markers for cancer. , 1994, Cancer research.
[46] H. Bartsch,et al. Validation of a new fluorometric assay for benzo[a]pyrene diolepoxide-DNA adducts in human white blood cells: comparisons with 32P-postlabeling and ELISA. , 1994, Carcinogenesis.
[47] M. Poirier,et al. Human exposure monitoring, dosimetry, and cancer risk assessment: the use of antisera specific for carcinogen-DNA adducts and carcinogen-modified DNA. , 1994, Drug metabolism reviews.
[48] K. Randerath,et al. 32P-postlabeling methods for DNA adduct detection: overview and critical evaluation. , 1994, Drug metabolism reviews.
[49] K. Hemminki,et al. Seasonal variation of aromatic DNA adducts in human lymphocytes and granulocytes. , 1993, Carcinogenesis.
[50] A. Miller,et al. Are female smokers at higher risk for lung cancer than male smokers? A case-control analysis by histologic type. , 1993, American journal of epidemiology.
[51] E. Bowman,et al. Polycyclic aromatic hydrocarbon-DNA adducts in human lung and cancer susceptibility genes. , 1993, Cancer research.
[52] P. Vodicka,et al. Optimization of an HPLC method for analyses of 32P-postlabeled DNA adducts. , 1993, Carcinogenesis.
[53] M. Poirier. Antisera specific for carcinogen-DNA adducts and carcinogen-modified DNA: applications for detection of xenobiotics in biological samples. , 1993, Mutation research.
[54] D P Ford,et al. Contribution of occupation and diet to white blood cell polycyclic aromatic hydrocarbon-DNA adducts in wildland firefighters. , 1993, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[55] P. Strickland,et al. Increased sensitivity for determination of polycyclic aromatic hydrocarbon-DNA adducts in human DNA samples by dissociation-enhanced lanthanide fluoroimmunoassay (DELFIA). , 1993, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[56] F. Perera,et al. HPRT and glycophorin A mutations in foundry workers: relationship to PAH exposure and to PAH-DNA adducts. , 1993, Carcinogenesis.
[57] D. Phillips,et al. DNA adducts in peripheral blood lymphocytes from aluminum production plant workers determined by 32P-postlabeling and enzyme-linked immunosorbent assay. , 1993, Environmental health perspectives.
[58] D. Phillips,et al. Results of an interlaboratory trial of 32P-postlabelling. , 1993, IARC scientific publications.
[59] P. Strickland,et al. Correlation between PAH airborne concentration and PAH-DNA adducts levels in coke-oven workers , 1993, International archives of occupational and environmental health.
[60] F. Perera,et al. Molecular and genetic damage in humans from environmental pollution in Poland , 1992, Nature.
[61] H. Bartsch,et al. An improved fluorometric assay for dosimetry of benzo(a)pyrene diol-epoxide-DNA adducts in smokers' lung: comparisons with total bulky adducts and aryl hydrocarbon hydroxylase activity. , 1992, Cancer research.
[62] F. Perera,et al. Cigarette smoking related polycyclic aromatic hydrocarbon-DNA adducts in peripheral mononuclear cells. , 1992, Carcinogenesis.
[63] G. Talaska,et al. 32P-postlabelling and mass spectrometric methods for analysis of bulky, polyaromatic carcinogen-DNA adducts in humans. , 1992, Journal of chromatography.
[64] A. C. Beach,et al. Human biomonitoring and the 32P-postlabeling assay. , 1992, Carcinogenesis.
[65] N. van Zandwijk,et al. Polycyclic aromatic hydrocarbon--DNA adducts in white blood cells from lung cancer patients: no correlation with adduct levels in lung. , 1992, Carcinogenesis.
[66] H. Bartsch,et al. Carcinogen mmetabolism and DNA adducts in human lung tissues as affected by tobacco smoking or metabolic phenotype: a case-control study on lung cancer patients , 1991 .
[67] J. van Benthem,et al. Immunocytochemical analysis of in vivo DNA modification. , 1990, Mutation research.
[68] F. V. van Schooten,et al. Determination of benzo[a]pyrene diol epoxide-DNA adducts in white blood cell DNA from coke-oven workers: the impact of smoking. , 1990, Journal of the National Cancer Institute.
[69] R. Albertini. Annual meeting of the environmental mutagen society , 1990 .
[70] C. Harris,et al. An applied synchronous fluorescence spectrophotometric assay to study benzo[a]pyrene-diolepoxide-DNA adducts. , 1985, Carcinogenesis.
[71] D. Phillips. Fifty years of benzo(a)pyrene , 1983, Nature.
[72] R. Gupta,et al. 32P-postlabeling analysis of non-radioactive aromatic carcinogen--DNA adducts. , 1982, Carcinogenesis.
[73] E C Miller,et al. Searches for ultimate chemical carcinogens and their reactions with cellular macromolecules , 1981, Cancer.
[74] I. Weinstein,et al. Quantitation of benzo(a)pyrene-deoxyguanosine adducts by radioimmunoassay. , 1980, Cancer research.
[75] I. Weinstein,et al. Detection of carcinogen–DNA adducts by radioimmunoassay , 1977, Nature.
[76] R. Harvey,et al. The reaction of (±)‐7α, 8β‐dihydroxy‐9β, 10β‐epoxy‐7,8,9,10‐tetrahydrobenzo(a)pyrene with dna , 1976 .
[77] K. Nakanishi,et al. Letter: Benzo[a]pyrene-nucleic acid derivative found in vivo: structure of a benzo[a]pyrenetetrahydrodiol epoxide-guanosine adduct. , 1976, Journal of the American Chemical Society.
[78] A. Hewer,et al. Metabolic activation of benzo(a)pyrene proceeds by a diol-epoxide , 1974, Nature.
[79] P. Grover,et al. Epoxides in polycyclic aromatic hydrocarbon metabolism and carcinogenesis. , 1974, Advances in cancer research.
[80] A. Borgen,et al. Metabolic conversion of benzo(a)pyrene by Syrian hamster liver microsomes and binding of metabolites to deoxyribonucleic acid. , 1973, Journal of medicinal chemistry.
[81] H. Gelboin. A microsome-dependent binding of benzo[a]pyrene to DNA. , 1969, Cancer research.
[82] P. Grover,et al. Enzyme-catalysed reactions of polycyclic hydrocarbons with deoxyribonucleic acid and protein in vitro. , 1968, The Biochemical journal.
[83] P. D. Lawley,et al. Evidence for the Binding of Polynuclear Aromatic Hydrocarbons to the Nucleic Acids of Mouse Skin : Relation between Carcinogenic Power of Hydrocarbons and their Binding to Deoxyribonucleic Acid , 1964, Nature.
[84] N. M. Kennaway,et al. The production of cancer by pure hydrocarbons. V , 1932, Proceedings of the Royal Society of London. Series B - Biological Sciences.
[85] J. W. Cook,et al. 106. The isolation of a cancer-producing hydrocarbon from coal tar. Parts I, II, and III , 1933 .